Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.19
0.29 (2.25%)
At close: Aug 15, 2025, 3:46 PM

Ginkgo Bioworks Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
561.57M 944.07M 1.32B 1.55B
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
48.7M 78.56M 113.73M 115.23M
Other Long-Term Assets
55.34M 55.83M 88.72M 43.99M
Receivables
22.44M 31.74M 82.47M 149.9M
Inventory
n/a 46K 4.36M 3.36M
Other Current Assets
18.73M 5.15M 12.35M 698K
Total Current Assets
602.74M 1B 1.45B 1.72B
Property-Plant & Equipment
598.15M 397.22M 715.53M 145.77M
Goodwill & Intangibles
72.51M 131.98M 171.25M 42.95M
Total Long-Term Assets
774.71M 663.59M 1.09B 347.94M
Total Assets
1.38B 1.67B 2.54B 2.07B
Account Payables
14.17M 9.32M 10.45M 8.19M
Deferred Revenue
30.6M 48.49M 47.82M 33.24M
Short-Term Debt
28.96M 19.93M 29.33M 747K
Other Current Liabilities
-2.34M 50.5M 36.59M 88.19M
Total Current Liabilities
107.27M 163.86M 172.96M 134.76M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
16.58M 24.43M 42.06M 190.58M
Total Long-Term Liabilities
554.13M 404.33M 630.08M 368.85M
Total Liabilities
661.39M 568.19M 803.04M 503.61M
Total Debt
467.73M 241.77M 442.59M 23.03M
Common Stock
5K 199K 190K 161K
Retained Earnings
-5.84B -5.29B -4.4B -2.3B
Comprehensive Income
-1.81M 1.48M -2.63M -1.72M
Shareholders Equity
716.06M 1.1B 1.74B 1.51B
Total Investments
48.7M 77.91M 113.73M 115.23M